127 related articles for article (PubMed ID: 24742875)
1. Pro-inflammatory cytokine levels are raised in female schizophrenia patients treated with clozapine.
O'Connell KE; Thakore J; Dev KK
Schizophr Res; 2014 Jun; 156(1):1-8. PubMed ID: 24742875
[TBL] [Abstract][Full Text] [Related]
2. Increased interleukin 23 (IL23) levels in schizophrenia patients treated with depot antipsychotic medication.
O'Connell KE; Thakore J; Dev KK
Cytokine; 2015 May; 73(1):196-8. PubMed ID: 25769808
[TBL] [Abstract][Full Text] [Related]
3. Different serine and glycine metabolism in patients with schizophrenia receiving clozapine.
Hons J; Vasatova M; Cermakova E; Doubek P; Libiger J
J Psychiatr Res; 2012 Jun; 46(6):811-8. PubMed ID: 22502820
[TBL] [Abstract][Full Text] [Related]
4. Levels of S100B are raised in female patients with schizophrenia.
O'Connell K; Thakore J; Dev KK
BMC Psychiatry; 2013 May; 13():146. PubMed ID: 23705829
[TBL] [Abstract][Full Text] [Related]
5. Increased serum S100B levels in chronic schizophrenic patients on long-term clozapine or typical antipsychotics.
Qi LY; Xiu MH; Chen DC; Wang F; Kosten TA; Kosten TR; Zhang XY
Neurosci Lett; 2009 Sep; 462(2):113-7. PubMed ID: 19539717
[TBL] [Abstract][Full Text] [Related]
6. Pro-inflammatory cytokine levels are elevated in female patients with schizophrenia treated with clozapine.
Yuan X; Wang S; Shi Y; Yang Y; Zhang Y; Xia L; Zhang K; Liu H
Psychopharmacology (Berl); 2022 Mar; 239(3):765-771. PubMed ID: 35080634
[TBL] [Abstract][Full Text] [Related]
7. Cytokine and adipokine alterations in patients with schizophrenia treated with clozapine.
Klemettilä JP; Kampman O; Seppälä N; Viikki M; Hämäläinen M; Moilanen E; Leinonen E
Psychiatry Res; 2014 Aug; 218(3):277-83. PubMed ID: 24837425
[TBL] [Abstract][Full Text] [Related]
8. Do proinflammatory cytokines play a role in clozapine-associated glycometabolism disorders?
Zhao T; Zhang K; Zhang Y; Yang Y; Ning X; Hu Y; Li X; Zhang Y; Xia L; Ren Z; Liu H
Psychopharmacology (Berl); 2021 Jul; 238(7):1979-1990. PubMed ID: 33774704
[TBL] [Abstract][Full Text] [Related]
9. Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics.
Xiu MH; Hui L; Dang YF; Hou TD; Zhang CX; Zheng YL; Chen DC; Kosten TR; Zhang XY
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1508-12. PubMed ID: 19720106
[TBL] [Abstract][Full Text] [Related]
10. [Effect of clozapine and risperidone on serum cytokine levels in patients with first-episode paranoid schizophrenia].
Lü LX; Guo SQ; Chen W; Li Q; Cheng J; Guo JH
Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1251-4. PubMed ID: 15567770
[TBL] [Abstract][Full Text] [Related]
11. The effects of clozapine on levels of total cholesterol and related lipids in serum of patients with schizophrenia: a prospective study.
Dursun SM; Szemis A; Andrews H; Reveley MA
J Psychiatry Neurosci; 1999 Nov; 24(5):453-5. PubMed ID: 10586536
[TBL] [Abstract][Full Text] [Related]
12. Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment.
de Witte L; Tomasik J; Schwarz E; Guest PC; Rahmoune H; Kahn RS; Bahn S
Schizophr Res; 2014 Apr; 154(1-3):23-9. PubMed ID: 24582037
[TBL] [Abstract][Full Text] [Related]
13. Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: the MOZART study.
Sacchetti E; Galluzzo A; Valsecchi P; Romeo F; Gorini B; Warrington L;
Schizophr Res; 2009 May; 110(1-3):80-9. PubMed ID: 19269791
[TBL] [Abstract][Full Text] [Related]
14. Serum cytokine profile in schizophrenic patients.
Eftekharian MM; Omrani MD; Arsang-Jang S; Taheri M; Ghafouri-Fard S
Hum Antibodies; 2019; 27(1):23-29. PubMed ID: 30103309
[TBL] [Abstract][Full Text] [Related]
15. Higher serum concentrations of tyrosine and glutamate in schizophrenia patients treated with clozapine, compared to in those treated with conventional antipsychotics.
Melkersson K; Lewitt M; Hall K
Neuro Endocrinol Lett; 2015; 36(5):465-80. PubMed ID: 26707048
[TBL] [Abstract][Full Text] [Related]
16. Clozapine protects bone mineral density in female patients with schizophrenia.
Lin CH; Huang KH; Chang YC; Huang YC; Hsu WC; Lin CY; Huang-Chih Chou F; Tsai GE; Lane HY
Int J Neuropsychopharmacol; 2012 Aug; 15(7):897-906. PubMed ID: 22014454
[TBL] [Abstract][Full Text] [Related]
17. Association between serum levels of glutamate and neurotrophic factors and response to clozapine treatment.
Krivoy A; Hochman E; Sendt KV; Hollander S; Vilner Y; Selakovic M; Weizman A; Taler M
Schizophr Res; 2018 Feb; 192():226-231. PubMed ID: 28599751
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum levels of tumor necrosis factor-alpha in clozapine-associated obesity in chronic schizophrenia.
Chen DC; Qi LY; Xiu MH; Cao LY; Wang F; Chen S; Wu GY; Kosten TA; Kosten TR; Zhang XY
Schizophr Res; 2008 Dec; 106(2-3):367-8. PubMed ID: 18835132
[No Abstract] [Full Text] [Related]
19. Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders.
Igue R; Potvin S; Bah R; Stip E; Bouchard RH; Lipp O; Gendron A; Kouassi E
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1695-8. PubMed ID: 21627977
[TBL] [Abstract][Full Text] [Related]
20. Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine.
Yamamori H; Hashimoto R; Ishima T; Kishi F; Yasuda Y; Ohi K; Fujimoto M; Umeda-Yano S; Ito A; Hashimoto K; Takeda M
Neurosci Lett; 2013 Nov; 556():37-41. PubMed ID: 24141084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
